Literature DB >> 22588661

Functional genomic methods to study estrogen receptor activity.

Siv Gilfillan1, Elisa Fiorito, Antoni Hurtado.   

Abstract

Estrogen Receptor (ER) is a nuclear receptor that mediates the actions of estrogen and tamoxifen. ER is expressed in a major fraction of human breast cancers. Recently, genomic maps for estrogen- and tamoxifen-ER have been published. Interestingly, estrogen and tamoxifen induce similar genomic interactions and both ligands have been shown to use co-operating factors. The interactions of these co-operating factors within ER regions have impact both on ER-DNA interactions and gene expression regulated by estrogen and tamoxifen. Moreover, the study of chromatin changes induced by these factors has also provided significant insight into our understanding of ER transcriptional regulation. This methods review describes some functional genomic methods to study the influence of both ER ligands and ER co-operating factors. The analysis of protein-DNA interactions and chromatin changes can be explored by using classical and novel methods such as Chromatin Immunoprecipitation (ChIP) or Formaldehyde-Assisted Isolation of Regulatory Elements (FAIRE). This review also explores the properties of each of these methods and the advantages of combining them with high throughput sequencing.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22588661     DOI: 10.1007/s10911-012-9254-4

Source DB:  PubMed          Journal:  J Mammary Gland Biol Neoplasia        ISSN: 1083-3021            Impact factor:   2.673


  23 in total

1.  ERalpha and ERbeta expression and transcriptional activity are differentially regulated by HDAC inhibitors.

Authors:  V Duong; A Licznar; R Margueron; N Boulle; M Busson; M Lacroix; B S Katzenellenbogen; V Cavaillès; G Lazennec
Journal:  Oncogene       Date:  2006-03-16       Impact factor: 9.867

2.  Genome-wide analysis of estrogen receptor binding sites.

Authors:  Jason S Carroll; Clifford A Meyer; Jun Song; Wei Li; Timothy R Geistlinger; Jérôme Eeckhoute; Alexander S Brodsky; Erika Krasnickas Keeton; Kirsten C Fertuck; Giles F Hall; Qianben Wang; Stefan Bekiranov; Victor Sementchenko; Edward A Fox; Pamela A Silver; Thomas R Gingeras; X Shirley Liu; Myles Brown
Journal:  Nat Genet       Date:  2006-10-01       Impact factor: 38.330

3.  Mapping short DNA sequencing reads and calling variants using mapping quality scores.

Authors:  Heng Li; Jue Ruan; Richard Durbin
Journal:  Genome Res       Date:  2008-08-19       Impact factor: 9.043

4.  A novel role for high-mobility group a proteins in cellular senescence and heterochromatin formation.

Authors:  Masashi Narita; Masako Narita; Valery Krizhanovsky; Sabrina Nuñez; Agustin Chicas; Stephen A Hearn; Michael P Myers; Scott W Lowe
Journal:  Cell       Date:  2006-08-11       Impact factor: 41.582

Review 5.  The role of hormonal therapy in the management of hormonal-receptor-positive breast cancer with co-expression of HER2.

Authors:  Aleix Prat; José Baselga
Journal:  Nat Clin Pract Oncol       Date:  2008-07-08

6.  Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype.

Authors:  Jonna Frasor; Jeanne M Danes; Barry Komm; Ken C N Chang; C Richard Lyttle; Benita S Katzenellenbogen
Journal:  Endocrinology       Date:  2003-07-10       Impact factor: 4.736

7.  Isolation of active regulatory elements from eukaryotic chromatin using FAIRE (Formaldehyde Assisted Isolation of Regulatory Elements).

Authors:  Paul G Giresi; Jason D Lieb
Journal:  Methods       Date:  2009-03-18       Impact factor: 3.608

8.  Regulation of ERBB2 by oestrogen receptor-PAX2 determines response to tamoxifen.

Authors:  Antoni Hurtado; Kelly A Holmes; Timothy R Geistlinger; Iain R Hutcheson; Robert I Nicholson; Myles Brown; Jie Jiang; William J Howat; Simak Ali; Jason S Carroll
Journal:  Nature       Date:  2008-11-12       Impact factor: 49.962

9.  Growth factor stimulation induces a distinct ER(alpha) cistrome underlying breast cancer endocrine resistance.

Authors:  Mathieu Lupien; Clifford A Meyer; Shannon T Bailey; Jérôme Eeckhoute; Jennifer Cook; Thomas Westerling; Xiaoyang Zhang; Jason S Carroll; Daniel R Rhodes; X Shirley Liu; Myles Brown
Journal:  Genes Dev       Date:  2010-10-01       Impact factor: 11.361

10.  Cellular reprogramming by the conjoint action of ERα, FOXA1, and GATA3 to a ligand-inducible growth state.

Authors:  Say Li Kong; Guoliang Li; Siang Lin Loh; Wing-Kin Sung; Edison T Liu
Journal:  Mol Syst Biol       Date:  2011-08-30       Impact factor: 11.429

View more
  9 in total

1.  Critical questions in mammary gland development, lactational biology and breast cancer.

Authors:  Mohamed Bentires-Alj; Teresa L Wood
Journal:  J Mammary Gland Biol Neoplasia       Date:  2012-06       Impact factor: 2.673

Review 2.  Estrogen Receptors: New Directions in the New Millennium.

Authors:  Sylvia C Hewitt; Kenneth S Korach
Journal:  Endocr Rev       Date:  2018-10-01       Impact factor: 19.871

3.  The 5p12 breast cancer susceptibility locus affects MRPS30 expression in estrogen-receptor positive tumors.

Authors:  David A Quigley; Elisa Fiorito; Silje Nord; Peter Van Loo; Grethe Grenaker Alnæs; Thomas Fleischer; Jorg Tost; Hans Kristian Moen Vollan; Trine Tramm; Jens Overgaard; Ida R Bukholm; Antoni Hurtado; Allan Balmain; Anne-Lise Børresen-Dale; Vessela Kristensen
Journal:  Mol Oncol       Date:  2013-12-03       Impact factor: 6.603

Review 4.  What's new in estrogen receptor action in the female reproductive tract.

Authors:  Sylvia C Hewitt; Wipawee Winuthayanon; Kenneth S Korach
Journal:  J Mol Endocrinol       Date:  2016-02       Impact factor: 5.098

5.  CTCF modulates Estrogen Receptor function through specific chromatin and nuclear matrix interactions.

Authors:  Elisa Fiorito; Yogita Sharma; Siv Gilfillan; Shixiong Wang; Sachin Kumar Singh; Somisetty V Satheesh; Madhumohan R Katika; Alfonso Urbanucci; Bernd Thiede; Ian G Mills; Antoni Hurtado
Journal:  Nucleic Acids Res       Date:  2016-09-15       Impact factor: 16.971

6.  Loss of progesterone receptor is associated with distinct tyrosine kinase profiles in breast cancer.

Authors:  Andliena Tahiri; Xavier Tekpli; Somisetty V Satheesh; Rik DeWijn; Torben Lüders; Ida R Bukholm; Antoni Hurtado; Jürgen Geisler; Vessela N Kristensen
Journal:  Breast Cancer Res Treat       Date:  2020-07-24       Impact factor: 4.872

Review 7.  Cooperating transcription factors mediate the function of estrogen receptor.

Authors:  Elisa Fiorito; Madhumohan R Katika; Antoni Hurtado
Journal:  Chromosoma       Date:  2012-11-29       Impact factor: 4.316

Review 8.  Exploring the effects of polymorphisms on cis-regulatory signal transduction response.

Authors:  Alasdair MacKenzie; Benjamin Hing; Scott Davidson
Journal:  Trends Mol Med       Date:  2012-12-19       Impact factor: 11.951

9.  Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles.

Authors:  Svitlana Vdovikova; Siv Gilfillan; Shixiong Wang; Mitesh Dongre; Sun Nyunt Wai; Antoni Hurtado
Journal:  Sci Rep       Date:  2018-05-09       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.